WallStreetZenWallStreetZen

NASDAQ: INGN
Inogen Inc Stock

Overview
ForecastEarningsRevenueDividendOwnership
$7.13-0.15 (-2.06%)
Updated Apr 30, 2025
INGN Price
$7.13
Fair Value Price
-$2.49
Market Cap
$189.16M
52 Week Low
$6.40
52 Week High
$13.33
P/E
-4.69x
P/B
1.09x
P/S
0.65x
PEG
N/A
Dividend Yield
N/A
Revenue
$335.71M
Earnings
-$35.89M
Gross Margin
46.1%
Operating Margin
-10.87%
Profit Margin
-10.7%
Debt to Equity
0.7
Operating Cash Flow
$6M
Beta
1.17
Next Earnings
May 5, 2025
Ex-Dividend
N/A
Next Dividend
N/A

INGN Overview

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine INGN's potential to beat the market

BBuy
  • Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
View All “A” Zen Rated Stocks
→

Zen Rating Component Grades

C
Value
B
Growth
D
Momentum
A
Sentiment
C
Safety
C
Financials
A
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical Device

Industry Rating
C
INGN
Ranked#27 of 108

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
Bioventus (BVS)
$7.31A
Electromed (ELMD)
$23.03A
Tactile Systems Technology (TCMD)
$14.12A
View Top Medical Device Stocks

Be the first to know about important INGN news, forecast changes, insider trades & much more!

INGN News

Overview

Due Diligence Score

–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how INGN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

INGN ($7.13) is overvalued by 386.61% relative to our estimate of its Fair Value price of -$2.49 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
INGN ($7.13) is not significantly undervalued (386.61%) relative to our estimate of its Fair Value price of -$2.49 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
INGN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more INGN due diligence checks available for Premium users.

Valuation

INGN fair value

Fair Value of INGN stock based on Discounted Cash Flow (DCF)

Price
$7.13
Fair Value
-$2.49
Undervalued by
386.61%
INGN ($7.13) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
INGN ($7.13) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
INGN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

INGN price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-4.69x
Industry
37.39x
Market
29.18x

INGN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
1.09x
Industry
3.94x
INGN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

INGN's financial health

Profit margin

Revenue
$80.1M
Net Income
-$9.8M
Profit Margin
-12.2%
INGN's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
INGN's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$296.2M
Liabilities
$122.3M
Debt to equity
0.7
INGN's short-term assets ($185.45M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
INGN's short-term assets ($185.45M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
INGN's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
INGN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$3.0M
Investing
$11.5M
Financing
-$260.0k
INGN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

INGN vs Medical Device Stocks

TickerZen RatingMarket Cap1d %P/EP/B
INGNB$189.16M-2.06%-4.69x1.09x
CVRXD$190.58M-0.95%-2.76x2.68x
MASSC$191.84M-0.73%-2.56x1.67x
LUNGC$192.22M-8.35%-3.35x2.24x
CATXD$181.43M+1.66%-1.99x0.62x
View Top Medical Device Stocks

Inogen Stock FAQ

What is Inogen's quote symbol?

(NASDAQ: INGN) Inogen trades on the NASDAQ under the ticker symbol INGN. Inogen stock quotes can also be displayed as NASDAQ: INGN.

If you're new to stock investing, here's how to buy Inogen stock.

What is the 52 week high and low for Inogen (NASDAQ: INGN)?

(NASDAQ: INGN) Inogen's 52-week high was $13.33, and its 52-week low was $6.40. It is currently -46.51% from its 52-week high and 11.41% from its 52-week low.

How much is Inogen stock worth today?

(NASDAQ: INGN) Inogen currently has 26,529,544 outstanding shares. With Inogen stock trading at $7.13 per share, the total value of Inogen stock (market capitalization) is $189.16M.

Inogen stock was originally listed at a price of $15.15 in Feb 14, 2014. If you had invested in Inogen stock at $15.15, your return over the last 11 years would have been -52.94%, for an annualized return of -6.62% (not including any dividends or dividend reinvestments).

How much is Inogen's stock price per share?

(NASDAQ: INGN) Inogen stock price per share is $7.13 today (as of Apr 30, 2025).

What is Inogen's Market Cap?

(NASDAQ: INGN) Inogen's market cap is $189.16M, as of May 2, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Inogen's market cap is calculated by multiplying INGN's current stock price of $7.13 by INGN's total outstanding shares of 26,529,544.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.